Загрузка...

An Antiestrogenic Activity Score for tamoxifen and its metabolites is associated with breast cancer outcome

PURPOSE: Endoxifen concentrations have been associated with breast cancer recurrence in tamoxifen-treated patients. However, tamoxifen itself and other metabolites also show antiestrogenic anti-tumor activity. Therefore, the aim of this study was to develop a comprehensive Antiestrogenic Activity Sc...

Полное описание

Сохранить в:

Библиографические подробности
Опубликовано в: :	Breast Cancer Res Treat
Главные авторы:	de Vries Schultink, A. H. M., Alexi, X., van Werkhoven, E., Madlensky, L., Natarajan, L., Flatt, S. W., Zwart, W., Linn, S. C., Parker, B. A., Wu, A. H. B., Pierce, J. P., Huitema, A. D. R., Beijnen, J. H.
Формат:	Artigo
Язык:	Inglês
Опубликовано:	2016
Предметы:	Article
Online-ссылка:	https://ncbi.nlm.nih.gov/pmc/articles/PMC5812686/ https://ncbi.nlm.nih.gov/pubmed/28005246 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s10549-016-4083-6
Метки:	Добавить метку Нет меток, Требуется 1-ая метка записи!

An Antiestrogenic Activity Score for tamoxifen and its metabolites is associated with breast cancer outcome

Схожие документы